RG

Rich Gliklich

North America, Massachusetts, United States, Boston

Description

Rich Gliklich is the Founder and CEO at OM1.

Investor Profile

Rich Gliklich has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in Canada.
  • Strong thematic focus on Bioinformatics, Biopharma, Clinical Trials.

Stage Focus

  • Seed (100%)

Country Focus

  • Canada (100%)

Industry Focus

  • Bioinformatics
  • Biopharma
  • Clinical Trials
  • Cloud Computing
  • Enterprise Software
  • Health Care
  • Health Diagnostics
  • Life Science
  • Machine Learning
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Rich Gliklich frequently co-invest with?

B
North America, New York, United States, Nyack
Co-Investments: 1
Debiopharm Innovation Fund
Europe, Vaud, Switzerland, Lausanne
Co-Investments: 1

Which angels does Rich Gliklich often collaborate with?

DF
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Rich Gliklich?

Altis Labs

Toronto, Ontario, Canada

Altis helps biopharma run faster and more successful clinical trials using AI models trained on the world's largest cancer imaging database.

BioinformaticsBiopharmaClinical TrialsCloud ComputingEnterprise SoftwareHealth CareHealth DiagnosticsLife ScienceMachine LearningPharmaceutical
SeedJun 21, 2023
Amount Raised: $6,002,574